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A B S T R A C T
Many biophysical techniques that are available to study the structure, function and dynamics of cellular con-
stituents require modiﬁcation of the target molecules. Site-speciﬁc labelling of a protein is of particular interest
for ﬂuorescence-based single-molecule measurements including single-molecule FRET or super-resolution mi-
croscopy. The labelling procedure should be highly speciﬁc but minimally invasive to preserve sensitive bio-
molecules. The modern molecular engineering toolkit provides elegant solutions to achieve the site-speciﬁc
modiﬁcation of a protein of interest often necessitating the incorporation of an unnatural amino acid to in-
troduce a unique reactive moiety. The Amber suppression strategy allows the site-speciﬁc incorporation of
unnatural amino acids into a protein of interest. Recently, this approach has been transferred to the mammalian
expression system. Here, we demonstrate how the combination of unnatural amino acid incorporation paired
with current bioorthogonal labelling strategies allow the site-speciﬁc engineering of ﬂuorescent dyes into pro-
teins produced in the cellular environment of a human cell. We describe in detail which parameters are im-
portant to ensure eﬃcient incorporation of unnatural amino acids into a target protein in human expression
systems. We furthermore outline puriﬁcation and bioorthogonal labelling strategies that allow fast protein
preparation and labelling of the modiﬁed protein. This way, the complete eukaryotic proteome becomes
available for single-molecule ﬂuorescence assays.
1. Introduction
The possibility to engineer a non-canonical amino acid carrying a
unique reactive side chain into a human protein of interest is highly
advantageous for biochemical and biophysical studies as suitable
probes like ﬂuorescent dyes, biotins, lipids, sugars, EPR labels, cross-
linkers etc can be attached to this protein via bioorthogonal chemistries
[1,2]. One example is super-resolution microscopy that allows to image
(biological) structures with unprecedented spatiotemporal resolutions
in the low nanometre range providing new opportunities to study and
quantitatively monitor biomolecules (for a recent review see [3]). In
this context, highly speciﬁc and dense labelling of the biological
structure with ﬂuorophores is required to achieve an optimal resolu-
tion. Site-speciﬁc engineering of molecular handles and ﬂuorophores is
also desired to equip proteins to be used for other biophysical techni-
ques (e.g. single-molecule FRET) and nanobiotechnology. In the context
of nanobiotechnology, it is the aim to produce functional nanos-
tructures built of a programmable nanomaterial and a functional bio-
molecule to create nanometre-sized machineries with high precision
[4,5]. This approach often requires the physical and ideally site-speciﬁc
connection of a biomolecule with a nanostructure. Hence, the site-di-
rected engineering of biophysical probes, molecular handles and mod-
iﬁcations has increasing importance to expand the structural and che-
mical diversity of proteins, which in turn increases the ﬂexibility and
chemical space for the design of biological nanostructures and bio-
physical assays [2,6–10]. However, the site-speciﬁc modiﬁcation of
(especially human) proteins is still a challenging task that, among
others, can be achieved via bioorthogonal chemistries based on an
unnatural amino acid (uaa) that has been incorporated into the protein
of interest. The uaa carries a unique reactive moiety that can be
exploited for highly selective bioorthogonal reactions [11,12,2]. An uaa
can be genetically encoded by reprogramming a rarely used codon or a
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non-sense codon in the gene of interest [10,13]. In bacterial and
mammalian expression systems, the Amber stop codon (TAG) is fre-
quently exploited for this purpose. E. coli rarely makes use of this codon
and human cells utilise this codon with lowest frequency to terminate
translation (TAG: 23%, TAA: 30%, TGA: 47% in Homo sapiens) [14,15].
In order to repurpose the Amber codon, a bioorthogonal tRNA / ami-
noacyl-tRNA synthetase (aaRS) pair is required that allows the coupling
of the uaa with high eﬃciency and extraordinary selectivity to a tRNA
that recognises the Amber codon thereby avoiding the abortion of
translation by the release factor at this site (Fig. 1A).
The uaa introduces a distinct reactive group into the protein that
can be utilised for coupling reactions, among them biocompatible
variations of the highly speciﬁc and catalyst-free click reactions (e.g.
strain-promoted azide-alkyne cycloaddition [SPAAC], and the strain-
promoted inverse electron demand Diels-Alder click reaction
[SPIEDAC]) as well as the Staudinger ligation (reviewed for example in
Lang et al. [16]) (Fig. 1B). Eﬃcient uaa incorporation was only recently
accomplished in human cells [14,17–22] opening up the possibility to
directly label a protein of interest with organic dyes in human cells to
perform for example direct super-resolved imaging of cellular structures
[23,24,18,25]. Moreover, uaa incorporation also allowed the site-spe-
ciﬁc ﬂuorescent labelling of eukaryotic proteins for (single-molecule)
FRET measurements, glycol-engineering, and the site-speciﬁc cross-
linking of biomolecular complexes [1,26]. Notably, uaa incorporation
into human proteins expressed in their native cellular environment
ensures that the protein adopts its native fold and carries all function-
ally important posttranslational modiﬁcations as we have recently de-
monstrated for the human Argonaute 2 protein [26]. This is a major
step forward as it enables single-molecule FRET measurements with
human proteins that hitherto evaded single-molecule interrogation as
they often cannot be produced in recombinant form.
Here, we explain step-by-step how unnatural amino acids can be
eﬃciently incorporated into proteins that are expressed in human cells.
We describe in detail the major obstacles and pitfalls and evaluate the
incorporation eﬃciencies for diﬀerent unnatural amino acids and cell
lines using diﬀerent transfection reagents. Moreover, we describe a fast
and eﬃcient workﬂow that allows the ﬂuorescent labelling and pur-
iﬁcation of these proteins and evaluate coupling eﬃciencies of diﬀerent
bioorthogonal reactions. Taken together, we wish to provide a practical
guide for the eﬃcient incorporation of unnatural amino acids in human
expression systems to allow researchers to exploit bioorthogonal che-
mistries in their ﬁeld of research.
2. Material and methods
2.1. Generation of expression plasmids
The eGFP expression plasmid that contains the eGFP Wildtype (WT)
sequence was purchased from addgene (#13031). The Amber codon
and the FLAG-tag was introduced at the given site using the
QuikChange II site-directed mutagenesis kit (Agilent). The C-terminal
His-tag was introduced making use of the Fusion® HD cloning kit
(Takara Bio USA, Inc.).
2.2. Cell culture
HEK 293 T and HeLa cells were grown on Dulbecco's Modiﬁed Eagle
Medium (DMEM) high glucose (4.5 g/l) buﬀered with HEPES without
phenol red (Thermo Fisher). Additionally, 1% (v/v) Penicillin/
Streptomycin and 10% (v/v) Fetal Bovine Serum (Sigma-Aldrich) was
added to the growth media. Cells were cultivated under standard con-
ditions (37 °C and 5% CO2). Upon cultivation, cells were passaged every
Fig. 1. (A) Incorporation of an unnatural
amino acid (uaa) into a protein using the
Amber suppressor strategy. Site-speciﬁc in-
troduction of the Amber stop codon (TAG) into
the gene of interest (GOI) usually leads to the
abortion of translation at this site and conse-
quently results in a shortened protein of in-
terest (POI). Co-transformation of additional
plasmids harbouring an engineered orthogonal
aminoacyl tRNA synthetase (aaRS) / tyrosyl-
tRNA (tRNA*CUA) pair charges the additional
tRNA with the unnatural amino acid. The tRNA
is optimised to work eﬃciently in the cellular
translation system leading to the incorporation
of the uaa into the protein strand and allows
expression of the full length protein. (B)
Protein labelling schemes based on bioortho-
gonal reaction schemes: the Staudinger-
Bertozzi ligation between a phosphine and an
organic azide (left), the strain-promoted azide-
alkin cycloaddition (SPAAC) reaction between
a cyclooctyne and an azide (middle) and the
strain-promoted inverse Diels Alder cycload-
dition (SPIEDAC) between a tetrazine and a
cycloalkene. The green sphere symbolises the
protein to which the ﬂuorophore is coupled.
The red sphere indicates the ﬂuorescent dye
linked to the protein via the bioorthogonal
reaction. (For interpretation of the references
to color in this ﬁgure legend, the reader is re-
ferred to the web version of this article.).
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2–3 days using 1ml Trypsin-EDTA (Sigma-Aldrich) to detach PBS-wa-
shed cells from a 10 cm dish and an appropriate amount of cells was
transferred to a new 10 cm dish containing 10ml of growth medium for
passaging.
2.3. Transfection of cells
For optimal DNA transfection conditions, a suitable number of HEK
293 T or HeLa cells were seeded into a culture dish to reach a con-
ﬂuency of ~70–80% on the day of transfection. For a 24-well culture
dish ~ 70 000 cells, for a 6-well culture dish ~ 200,000 cells were
seeded per well and ~ 1.5×106 cells were used for a 10 cm culture
dish. Prior transfection, the culture medium was exchanged with fresh
untreated growth medium or growth medium containing an unnatural
amino acid (see the following chapter: incorporation of unnatural
amino acids). In this study, either Lipofectamine® 2000 or JetPRIME®
was used to transfect human cells.
2.4. Transfection with Lipofectamine® 2000
If not noted otherwise, cells were transfected according to supplier's
information (Thermo Fisher). The transfection mix was prepared from
two separate solutions. For the transfection of cells grown in a 24-well
format, 50 µl and for cells grown in a 6-well format, 150 µl of serum-
free Opti-MEM™ medium was used to dilute 500 or 2500 ng of plasmid
DNA, respectively. In a second solution, containing equal volumes of
Opti-MEM™, 1–2.5 µl (24 well) or 5–12.5 µl of Lipofectamine® 2000
were added and mixed with the DNA-solution. After 5min of incuba-
tion, the transfection mix was directly transferred to the cells and ex-
pression of proteins was performed for at least 16 h.
2.5. Transfection with JetPRIME®
If not noted otherwise, cells were transfected according to supplier's
information (Polyplus-transfection, VWR). Brieﬂy, 0.5 (24 well format),
2.0 (6 well format) or 10.0 µg (10 cm dish) of plasmid-DNA was diluted
in 50 µl, 200 or 500 µl of JetPRIME-buﬀer, respectively. After dilution,
1, 4 or 20 µl of JetPRIME (1:2 DNA to jetPRIME ratio (w/v)) transfec-
tion reagent was directly added to the DNA-solution and incubated for
10min at room temperature. The transfection mix was directly trans-
ferred to the cells and expression of proteins was performed for at least
16 h.
2.6. Incorporation of unnatural amino acids into proteins
In this study, we used two diﬀerent systems that expand the genetic
code of a human cell and allow the incorporation of either trans-cy-
clooctene L-lysine (TCO*A) or p-Azido-L-phenylalanine (AzF) into eGFP
[26]. TCO incorporation was mediated by an orthogonal tRNA/ aaRS
pair from Methanosarcina mazei co-encoded on a single plasmid
(plasmid was supplied by Edward Lemke, EMBL Heidelberg, Germany)
[27]. Incorporation of AzF is based on the orthogonal tRNATyrCUA (tRNA
fusion construct from H. sapiens and Bacillus stearothermophilus) and the
E. coli aaRS encoded on two separate plasmids (plasmid was supplied by
T. Huber, Rockefeller University New York, USA) [28]. For transfection
of human cells, conditions that were introduced above were used. In
addition to the plasmids that encode the respective orthogonal tRNA
and aaRS pair, the eGFPT39Amber expression vector was transfected. The
total amount of plasmid DNA and transfection reagent was identical to
the procedures described above.
TCO*A and AzF were obtained from SiChem (Bremen, Germany)
and ChemImpex International (Wood Dale, USA), respectively. The
uaas were dissolved in 200mM NaOH and 15% DMSO to yield a
100mM stock solution that can be stored at − 20 °C. At the day of
transfection, a working solution of 25mM uaa was generated by a 1:4
dilution with 1M Hepes/KOH, pH 7.5. Prior transfection, the medium
was exchanged to freshly prepared growth medium, containing the
respective uaa in the desired concentration (50 µM were already suﬃ-
cient for optimal incorporation of each uaa).
The eﬃciency of the uaa incorporation was monitored by ﬂuores-
cence microscopy of living cells (Zeiss Axiovert 35 microscope con-
nected to a Color view soft imaging system). For acquisition of ﬂuor-
escence-images a ﬁlter-block (λex = 450–490 nm/ λem =515–565 nm)
was used and pictures of cells were taken with an exposure time of 5 s.
2.7. Puriﬁcation and labelling of modiﬁed proteins
For protein extraction, harvested cells containing the modiﬁed
protein were resuspended in 150 µl of IP-lysis buﬀer (25mM Tris-HCl
pH 7.5, 150mM NaCl, 1% NP40, supplemented with cOmplete™
(Roche) protease inhibitor) per 1× 106 cells and incubated on ice for
15min. After incubation, cell debris was removed by centrifugation at
20,000×g for 15min at 4 °C. The clariﬁed supernatant was applied to
either ANTI-FLAG®M2 beads (Sigma-Aldrich) for FLAG-tagged proteins
or to Ni-NTA Magnetic Agarose Beads (Qiagen) for His6-tagged pro-
teins. Beads were incubated with the cell lysate at 4 °C for 1–3 h in
1.5 ml reaction tubes while rotating overhead. Unbound proteins were
removed by 3 wash steps with either HisA buﬀer (50mM Tris/HCl pH
7.5, 200mM NaCl, 20mM imidazole and 0.5% Tween-20 (v/v)) for His-
beads or FLAG-I buﬀer (50mM Tris/HCl pH 7.5, 200mM NaCl and
0.5% Tween-20 (v/v)) for FLAG-beads. Enriched, puriﬁed proteins were
directly labelled while they were bound to the beads. Elution of eGFP
was performed using either HisB (50mM Tris-HCl pH 7.5, 200mM
NaCl, 250mM imidazole and 0.5% Tween (v/v)) or FLAG-I buﬀer
supplemented with 300 µg/µl 3xFLAG peptide (Sigma-Aldrich) for
60min on ice, respectively. For labelling, a 10mM stock solution of the
respective dye was prepared by dissolving the dye in an appropriate
volume of water-free DMSO (Phosphine-DL650 purchased from Thermo
Fisher, DBCO-Cy5 and Tetrazine-Cy5 from Jena Biosciences).
For labelling, an equal volume to the volume of the beads was
added, containing the respective dye concentration (in most cases
200 µM) and labelling was performed at 37 °C for 2 h while shaking the
reaction tube (300 rpm). When uaa-modiﬁed eGFP was labelled on the
beads, excessive dye was removed by 2–3 washing steps using HisA or
FLAG-I that contain 2% (v/v) Tween-20. Another 4–5 washing steps
using HisA or FLAG-I buﬀer and transfer to a new reaction tube were
suﬃcient to remove most of the uncoupled dye molecules from the
samples. Elution from the aﬃnity beads was performed as described
above.
2.8. Western blot analysis
Prior to Western blot analysis, samples were mixed with denaturing
Laemmli Buﬀer (ﬁnal concentration: 62.5 mM Tris/HCl pH 6.8, 10%
glycerol, 2% SDS, 0.01% bromophenol blue supplemented with 2% β-
mercaptoethanol) and samples were incubated at 95 °C for 5min.
Subsequently, samples were loaded onto a 12% SDS gel and separated
in an electric ﬁeld with a constant current of 30 mA per gel. After se-
paration, proteins were transferred to an AmershamTM ProtranTM
0.45 µm NC nitrocellulose membrane (GE Healthcare) by semidry
blotting in Towbin buﬀer (25mM Tris-HCl pH 8:3, 192mM glycine,
20% (v/v) methanol). For immunodetection of eGFP, a monoclonal
mouse-anti-GFP antibody (#11814460001, Roche; 1:1000) was used.
Immunodetection of α-Tubulin was performed with a monoclonal
mouse-anti α-Tubulin antibody (#T90026, Sigma-Aldrich, 1:1000). An
Alexa Fluor 647 labelled goat-anti-mouse secondary antibody
(#A21236, Thermo, 1:10000) was used for detection of the antibody
sandwich on a ﬂuorescence scanner (FLA-5000, FUJIFILM, λex
= 635 nm, ﬁlter module 557–270/01).
For the quantiﬁcation of the Western blot signals, the open source
code software ImageJ [29] was used. First, the background was sub-
tracted with an ImageJ-integrated process and after processing, signal
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intensities were determined. In order to determine the expression eﬃ-
ciency of the eGFP-variants, the eGFP Western Blot signal was nor-
malized to the respective α-Tubulin signal.
2.9. Native gel analysis
For native gel analysis, samples were mixed with 5x native loading
dye (ﬁnal concentrations: 60mM Tris/HCl pH 6.8% and 12.5% gly-
cerol) and loaded on a non-denaturing 15% PAA gel. Gel electrophor-
esis was performed using native Laemmli running buﬀer (24mM Tris/
HCl pH 8.3 and 192mM Glycine) at 4 °C for 1–3 h. Fluorescent signals
were visualised using a FLA7000 scanner (GE Healthcare) and ﬁnally
gels were transferred to a staining solution (0.02% CBB-G250, 5%
aluminium sulphate, 10% ethanol and 2% ortho-phosphoric acid) for
colloidal Coomassie staining. After staining, gels were destained in
destaining solution (10% Ethanol and 2% ortho-phosphoric acid) and
visualised on a gel documentation device (BioDoc-It imaging system,
UVP).
2.10. Determination of the FLAG-eGFP concentration after FLAG-IP
In order to determine eGFP yields, it was of interest to measure
eGFP concentrations after enrichment of FLAG-eGFP using ANTI-FLAG®
M2 agarose beads. Due to low protein yields, concentration determi-
nation via UV/Vis spectroscopy was diﬃcult. Therefore, we used pur-
iﬁed recombinant eGFP produced in E. coli and a linear range of known
eGFP concentrations (0.2 – 1.4 µM) was loaded onto a native PAA gel to
create a standard curve. The standard curve was employed to determine
the concentration of a eGFP- elution sample derived from a FLAG-IP
puriﬁcation. eGFP signals were detected via a ﬂuorescence scan
(FLA7000, GE Healthcare, blue channel: λex = 473 nm, Y520 ﬁlter, red
channel: λex = 635 nm, R670 ﬁlter), signal intensities were determined
with ImageJ, and eGFP concentration from the FLAG-IPs were extra-
polated from the standard curve.
2.11. Determination of labelling eﬃciency
For determination of the labelling eﬃciency, equal amounts of
eGFPAzF bound to ANTI-FLAG® M2 agarose beads were incubated with
increasing concentrations of ﬂuorescent dyes (0–500 µM). After in-
cubation at 37 °C for 2 h, excessive dye was removed by several wash
steps using FLAG-I that contained 2% (v/v) Tween-20 and one ﬁnal step
using FLAG-I. Elution was performed with FLAG-I buﬀer containing
300 µg/µl 3xFLAG peptide and equal amounts from each sample were
mixed with 5x native loading dye and loaded onto a native PAA gel. As
labelled eGFP migrated faster in the native gel, labelling eﬃciency
could be directly calculated as the ratio of the ﬂuorescence signal of the
dye-labelled eGFP and the ﬂuorescing unlabelled eGFP.
2.12. Absorption spectroscopy analysis
All absorption spectroscopy measurements were performed on a
Beckman DU® 640 spectrophotometer using a SUPRASIL® Quartz pre-
cision cell ultra-micro cuvette (Hellma, 10×4.5mm, 120 µl). For the
determination of eGFP concentrations from a single 6-well culture dish,
cells were transfected either with wild-type (wt) eGFP or eGFPT39AzF in
the presence of the AzF tRNA/aaRS expression system and 300 µM AzF.
After 48 h of expression, cells were harvested and washed with PBS. The
pellet was resuspended in 100 µl 50mM Tris/HCl pH 7.5 and 150mM
NaCl and cells were lysed by sonication. Cell debris was removed by
centrifugation (21,000 g, 30min and 4 °C) and the supernatant was
transferred to an ultra-micro cuvette and absorbance was measured at
488 nm. The total amount of eGFP per 6-well was determined using the
Lambert-Beer law and an absorption coeﬃcient of 56 000M−1 cm−1
for eGFP.
3. Results and discussion
In order to exploit the experimental possibilities of an uaa-carrying
human protein, the expression of the uaa-modiﬁed protein as well as
puriﬁcation and labelling procedures must be optimised and estab-
lished. We guide the reader through such an expression, puriﬁcation
and labelling protocol that can be applied to any protein of choice
pointing out important points to consider when planning the experi-
ment as well as experimental tips and tricks.
3.1. Optimising the incorporation eﬃciency of unnatural amino acids in
mammalian cells
The production of suﬃcient amounts of protein that carry the de-
sired uaa is crucial for many downstream applications. Hence, it is
important to optimise the uaa incorporation eﬃciency. Typically, the
protein of interest will be cloned in a suitable expression vector that
allows stable constitutive or inducible expression in mammalian cells.
Please note, that the gene encoding the protein of interest (POI) must be
free of an Amber stop codon. As 23% of human genes make use of the
Amber stop codon [15], the WT sequence of the respective gene must be
checked before cloning. If an Amber stop codon is present, it should be
replaced by an alternative stop codon to allow the mutation of a natural
codon to an Amber stop codon to facilitate the site-speciﬁc incorpora-
tion of the uaa. Several parameters, among them the choice of cell line,
the transfection reagent, the uaa concentration, the uaa type, the ex-
pression plasmid to tRNA/aaRS ratio and the expression time inﬂuence
the protein yield. Here, we screened transfection and expression con-
ditions for two commonly used unnatural amino acids, namely p-Azido-
L-phenylalanine (AzF) and trans-cyclooctene L-lysine (TCO*A). We
chose the enhanced green ﬂuorescent protein (eGFP) as model system
as the successful incorporation of the uaa can be easily followed and
quantiﬁed by the production of the ﬂuorescent full-length eGFP (Fig. 2).
We mutated the codon at position 39 to an Amber stop codon (TAG) to
enable the incorporation of the uaa at this site instead of the naturally
encoded threonine. eGFP expression is driven from the commercially
available pcDNA3 expression plasmid, which ensures high constitutive
expression levels in mammalian cells. For the incorporation of AzF two
additional expression plasmids are required, one encoding the ortho-
gonal tRNATyrCUA (a tRNA fusion construct from H. sapiens and Bacillus
stearothermophilus) and a second plasmid for the expression of an ad-
ditional aaRS from E. coli [28]. The orthogonal tRNA/aaRS pair from
Methanosarcina mazei required for the incorporation of TCO*A is co-
encoded on a single plasmid [14,27,17].
First, we tested which plasmid ratios result in eﬃcient uaa in-
corporation (Fig. 2A/B and C). In case of AzF incorporation, a
pcDNAeGFP: tRNA plasmid: aaRS plasmid ratio of 10:9:1 or 10:9.5:0.5
yielded best results as detected by the number of ﬂuorescent cells
(imaged after 20 h) and Western blot analysis of cell lysates after 24 h
(Fig. 2A/B). For the incorporation of TCO*A, a pcDNAeGFP: tRNA/aaRS
plasmid ratio of 5:1 resulted in most eﬃcient incorporation of the uaa
(Fig. 2C). Incorporation of the uaa was only successful if all respective
expression plasmids were transfected [26]. Expression yields are also
dependent on the concentration of uaa added to the cells during
transfection. Hence, we tested a wide range of AzF and TCO con-
centrations (0–800 µM). The uaa was added directly to the growth
medium prior or during transfection (both works equally well). Ex-
pression of ﬂuorescent eGFP was dependent on the presence of the
unnatural amino acid and an AzF and TCO*A concentration of>
50–400 µM resulted in most eﬃcient eGFP expression for both systems
(Fig. 2D/E and Fig. S1). However, in our hands, TCO*A incorporation
is less eﬃcient than AzF incorporation (Fig. 2D/E). Recently, Nikic
et al. found that the aaRS from Methanosarcina mazei used for the in-
corporation of TCO*A contains a nuclear localisation sequence and
consequently, the aaRS is localised to the nucleus reducing uaa in-
corporation in the cytoplasm [25]. Engineering of a strong nuclear
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export sequence to the aaRS led to a predominantly cytoplasmatic lo-
calisation of the protein and a 14-fold increase in Amber suppression
eﬃciencies. Usage of the optimisedM. mazei aaRS should therefore lead
to better expression of TCO-containing proteins.
We furthermore tested whether the human cell line HeLa or HEK293
is more suited for uaa incorporation. We consistently found that the
Amber suppression strategy works more eﬃciently in HEK293 cells
(Fig. 3A). A wide range of transfection reagents can be used for mam-
malian cell transfection. In order to evaluate whether the choice of
transfection reagent inﬂuences incorporation eﬃciencies, we tested
Lipofectamine® and jetPRIME®, two frequently used transfection re-
agents. Interestingly, incorporation of TCO*A and AzF into eGFP was
more eﬀective when jetPRIME was used for transfection (Fig. 3A). This
has been observed for expression in HeLa (lanes 1–8) as well as HEK293
cells (lanes 9–16). Finally, we quantiﬁed the eGFP expression level in a
16–72 h time-window after transfection of the cells. It is important to
note that transfection combined with uaa treatment seemed to trigger
cell death in HeLa cells as the cells detached from the culture dish
approximately 24 h after transfection. In contrast, HEK293 cells grow
normally for extended periods of time. Western blot analysis of cell
lysates revealed that a maximum eGFPAzF and eGFPTCO expression level
was reached after 48 and 64 h, respectively, when using HEK293 cells
as expression system (Fig. 3B/C). Expression of wt eGFP yielded ap-
proximately 5 µg eGFP per 6-well (approximately three million cells)
and expression of eGFPT39AzF yielded 1.2 µg eGFP per 6-well.
eGFPT39TCO levels are signiﬁcantly lower yielding only 11%, 21% and
51% of full-length eGFPT39TCO as compared to eGFPT39AzF after 16, 24
and 48 h of expression, respectively (Fig. S3).
In conclusion, most eﬃcient uaa incorporation and highest eGFPuaa
yields were achieved when the unnatural amino acid AzF was in-
corporated. Optimal AzF incorporation eﬃciencies were observed if i)
an equal amount of target protein expression plasmid and expression
plasmid that encodes the bioorthogonal aaRS was used, ii) an uaa
concentration of 50–400 µM was added to the cells, iii) JetPrime was
used as transfection reagent, iv) HEK293 cells were used for protein
expression and v) cells were harvested 48 h after transfection.
3.2. Puriﬁcation of proteins carrying an unnatural amino acid
Prior to biophysical or biochemical characterisation of the POI, the
protein should be puriﬁed to homogeneity. Here, a wealth of chroma-
tographic puriﬁcation schemes can be used. We established a small-
scale puriﬁcation scheme to separate uaa-modiﬁed proteins from the
cellular content, which is especially important for subsequent (ﬂuor-
escent) labelling of the protein via bioorthogonal chemistries. As the
Amber stop codon is frequently used in human translation, there is a
high number of endogenous proteins that also carry the uaa modiﬁca-
tion. Consequently, addition of a reactive ﬂuorophore to the cell extract
results in a broad range of unwanted labelled proteins (Fig. 4A). We
furthermore found that cells derived from a single 6-well plate (ap-
proximately 2–3×106 cells) provide suﬃcient material for small-scale
puriﬁcation, which allows to follow the puriﬁcation process on Coo-
massie-stained SDS polyacrylamide gels. Thereby, hour-long prepara-
tion and puriﬁcation procedures that might negatively inﬂuence the
activity or multimerisation state of a sensitive protein or protein com-
plex are avoided. Here, we tested the histidine‐ and FLAG-tag that are
commonly used for protein puriﬁcation via aﬃnity chromatography or
immunoprecipitation, respectively. To this end, either the histidine‐ tag
Fig. 2. Optimisation of unnatural amino acid incorporation into eGFP using the Amber suppression strategy. (A) Fluorescence images of HEK 293 T cells
expressing eGFPT39AzF at diﬀerent plasmid ratios for the plasmids encoding the orthogonal tRNA, aminoacyl tRNA synthetase (aaRS) and the protein of interest
(pcDNAeGFPT39Amber plasmid). In all cases, the p-azido-L-phenylalanine (AzF) concentration used was 300 µM. (B) eGFPAzF expression levels are detected by Western
blot analysis for the conditions shown in (A). Quantiﬁcation of eGFPAzF expression for the conditions chosen in (A). (C) eGFPT39TCO expression levels detected via
Western blot at diﬀerent plasmid ratios for the plasmid encoding the orthogonal tRNA/aaRS and the pcDNAeGFPT39Amber plasmid. In all cases, the TCO concentration
was 300 µM. Quantiﬁcation of eGFPAzF expression for the diﬀerent plasmid ratios. (D and E) Addition of increasing amounts of AzF or TCO*A to the transfection
mixture results in a maximum incorporation eﬃciency at uaa concentrations of> 50 µM, respectively. Western blots and quantiﬁcation are analogous to (B-C). All
eGFPuaa quantiﬁcations were normalized to α-tubulin expression.
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(eGFP6xHis) or a FLAG-tag (eGFPFLAG) was genetically engineered to the
C-terminus of eGFP and puriﬁcation was carried out using either Ni-
NTA magnetic beads (eGFP6xHis) or anti-FLAG agarose beads
(eGFPFLAG) in 1.5 ml reaction tubes. In general, a C-terminal tag is
preferred as this allows the puriﬁcation of the full-length protein. Please
note that in some instances, the placement of a tag at either the N-
terminus or C-terminus of a protein is detrimental to protein folding
and/or function and if possible, the inﬂuence of the tag on a protein
function should be evaluated via a functional assay. Ni-NTA puriﬁca-
tion of eGFP6xHis resulted in a number of contaminating proteins in the
eluate fraction (Fig. 4B lanes 3 and 9). In contrast, the anti FLAG-bead
eluate only showed two major bands (Fig. 4B lanes 6 and 12). One of
the protein bands corresponds to eGFP as evident from immunodetec-
tion (not shown) and the ﬂuorescence scan of an SDS gel on which the
eluate fraction was analysed after on-bead labelling of eGFPT39*uaa
(Fig. 4B). The protein with an apparent molecular weight of approxi-
mately 50 kDa is most likely a previously described contamination (the
serine/threonine kinase STK38) of the FLAG-tag-based puriﬁcation
scheme [30]. In order to purify the POI to homogeneity, the protein can
be equipped with two tags allowing a two-step puriﬁcation [31]. We
recently showed that the double-puriﬁcation via ﬁrst the FLAG-tag
followed by a second puriﬁcation step via the His-tag resulted in highly
pure protein preparations suitable to perform bioorthogonal reactions
[26]. Alternatively, the widely employed TAP (tandem aﬃnity pur-
iﬁcation) tag could be used, which results in homogeneously pure
protein samples [32]. The successful incorporation of the uaa and the
identity of the protein should be checked employing mass spectrometry
(MS). However, larger amounts of protein are required for the MS
analysis. Moreover, if possible, the activity and folding of the protein
should be checked to evaluate whether the introduction of an uaa
changed the biochemical behaviour of the protein.
3.3. Suitable bioorthogonal chemistries for site-speciﬁc protein modiﬁcation
Over the last years, new chemistries were established that allow the
coupling of functional groups to a diverse range of sidechains pro-
grammed via the unnatural amino acids [1]. These developments aimed
to render the coupling reaction to be highly speciﬁc, rapid and eﬃcient
under physiological conditions to ensure high labelling eﬃciencies and
to preserve the native state of the protein. eGFPAzF was subjected to two
reaction schemes: i) the relatively slow reaction between an azide and a
phosphine group in a reaction called Staudinger Ligation [33] (low
Fig. 3. Evaluation of transfection conditions and expression time. (A) eGFPAzF expression levels in HeLa (left) or HEK293 (right) cells. Cells were transfected
with diﬀerent amounts of Lipofectamine® or JetPrime® and eGFP expression was detected by Western blot analysis 24 h after transfection. P-azido-L-phenylalanine
(AzF) concentration used for transfection was 300 µM. (B) Time-dependency of eGFPuaa expression as determined by Western blot analysis of cell lysates 16, 24, 40,
48, 64 and 72 h after transfection with JetPrime® (AzF and TCO*A concentration 300 µM each). All eGFPuaa quantiﬁcations were normalized to α-tubulin expression.
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10−3 M−1 s−1 range [34]) and ii) the slightly faster strain-promoted
alkyne-azide cycloaddition (SPAAC) between the azide group and a
strained cyclooctyne [35,27] (approximately 10−2 to 1M−1 s−1
[36,27,37]) (Fig. 1B). Both reactions follow second-order kinetics and
hence, the reaction rate depends on the concentration of the reactants.
Therefore, we tested diﬀerent concentrations (5–400 µM) of the re-
active dyes while keeping the eGFP concentrations constant (~ 0.6 µM)
to determine optimal dye concentrations for the labelling reaction. We
recommend to perform the labelling reaction directly on the beads used
for puriﬁcation of the protein. This way, the protein concentration is
comparably high supporting the second-order reaction kinetics of both
chemistries. But more importantly, the excess of dye used for the cou-
pling reaction can be removed upon washing of the bead-coupled
protein thereby avoiding time-consuming puriﬁcation via additional
chromatographic steps. Coupling of the dye via the Staudinger ligation
required 200 µM of phosphine-dye to reach the maximum labelling
degree (Fig. 4C, Fig. S2). Here, a labelling eﬃciency of about 70% was
achieved (Fig. 4C). The reaction was completed after 2 h when the in-
cubation was carried out at 37 °C. When the SPAAC reaction was em-
ployed, 200 µM of DBCO-modiﬁed dye was suﬃcient to reach the
maximum labelling degree with a labelling eﬃciency of about 73%
under otherwise identical conditions (Fig. 4C, Fig. S2). The fact that the
azide group will be reduced in the chemical environment of the cell
represents a drawback of azide-based coupling chemistries [12]. Hence,
labelling eﬃciencies will never reach 100%. However, 100% labelling
eﬃciency is often not necessary for many downstream applications.
Additionally, we tested the strain-promoted inverse Diels Alder cy-
cloaddition (SPIEDAC) between TCO and a tretrazine moiety. This re-
action is known to be very fast with reaction rates of 1–104 M−1 s−1
[38] but it has to be noted that TCO can also undergo conversion to the
less reactive cis-cyclooctene [39]. Here, maximum labelling was al-
ready achieved at very low concentrations of the tetrazine-coupled dye
(5 µM) (Fig. 4C). Another factor that has to be considered is the spe-
ciﬁcity of the labelling reaction as oﬀ-target labelling and biophysical
analysis of contaminating proteins alongside the target protein yields
ambiguous results. In this respect, the SPAAC reaction yielded sig-
niﬁcantly more oﬀ-target labelling products than the Staudinger liga-
tion and SPIEDAC reaction (Fig. 4C). The SPIEDAC reaction did not
result in visible oﬀ-target labelling, rendering this reaction more sui-
table for downstream ﬂuorescence-based analysis of the labelled pro-
tein. A second puriﬁcation step can yield highly pure protein even when
the SPAAC reaction or Staudinger Ligation was employed for labelling.
This protein-speciﬁc puriﬁcation can also be executed when using a
target-speciﬁc antibody for single-molecule pulldown experiments to
Fig. 4. Puriﬁcation and labelling of eGFPuaa. (A) Fluorescence scan of a SDS polyacrylamide gel loaded with HEK 293 T expressing eGFPT39Amber without (lane 1,
2) and with (lane 3, 4) p-azido-L-phenylalanine (AzF), and with (lane 3, 4) or without (lane 1,2) transfection of plasmids expressing tRNATyrCUA and aminoacyl tRNA
synthetase (aaRS). Lane 2 and 4 shows cell lysates incubated with 400 µM DyLight650 (DL650), cell lysates in lane 1 and 3 were not incubated with the ﬂuorophore
that carries a phosphine group as reactive moiety. Lanes 5–8 show the respective Coomassie-stained gel. (B) Coomassie stain and ﬂuorescence scan of an SDS gel
loaded with site-speciﬁcally labelled eGFPT39AzF*DL650. Full-length eGFPT39AzF was puriﬁed and enriched via its C-terminal His- or FLAG-tag using anti FLAG agarose
beads or Ni-NTA magnetic beads. On-bead labelling was performed using 200 µM of the phosphine-modiﬁed dye DyLight650 that reacts with the azide group of AzF.
Thus, a ﬂuorescent signal for eGFPT39AzF*DL650 could be detected after elution from the beads (Elu), while no signal was present in the input (Inp) or supernatant
(Sup). (C) Titration of increasing concentrations (0–400 µM) of reactive dye (lane 2–7: phosphine-DL650, lane 9–14: DBCO-Cy5, lane 16–21: Tetrazine-Cy5) to C-
terminally FLAG-tagged eGFPuaa variants (lane 1–14: eGFPAzF, lane 15–21: eGFPTCO*A). Reaction products are separated on a SDS polyacrylamide gel after incubation
for 2 h at 37 °C. The arrow indicates the protein of interest eGFP. The star (*) indicates a labelled protein contamination that is most likely a previously described
contamination (the serine/threonine kinase STK38) of the FLAG-tag-based puriﬁcation scheme.
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perform smFRET measurements on immobilised molecules thereby
ensuring the selective immobilisation and analysis of the POI [26]. It is
noteworthy, that – in contrast to the phosphine-modiﬁed dye - the
DBCO- and tetrazine-modiﬁed dyes undergo extensive interactions with
the agarose beads. Multiple washing steps did not lead to the removal of
the dye and a high fraction of free dyes are found in the elution fraction
alongside the POI. The presence of free dye can also cause problems in
the downstream analysis of the protein.
For (single-molecule) FRET applications, the site-speciﬁc coupling
of a donor and acceptor ﬂuorophore is required. For the introduction of
two distinct ﬂuorophores into a single polypeptide chain, diﬀerent
strategies were developed [18]. One option is the use of a single cy-
steine and an uaa for labelling exploiting the diﬀerent chemistries of the
side chains for speciﬁc coupling [40]. Another possibility is the in-
corporation of diﬀerent unnatural amino acids at the chosen sites. Here,
a combination of diﬀerent orthogonal pairs combined with respective
non-sense codons (e.g. the amber and the opal stop codon) were shown
to yield full-length proteins but with lower yields as compared to a
single uaa incorporation event [22]. Alternatively, recoding of a con-
ventional triplet stop codon in combination with the use of a quadruplet
codon [41] (requiring an additional orthogonal ribosome) for the re-
spective uaa and subsequent speciﬁc labelling was shown to lead to site-
speciﬁc and quantitative labelling of a single protein with donor and
acceptor ﬂuorophore to allow FRET measurements [42,43]. However,
this approach was only realised in the E. coli expression system so far.
Double-labelling can also be achieved when the same uaa is in-
corporated at two independent sites and donor and acceptor dye are
added simultaneously to the protein [26]. This way, the protein will be
stochastically labelled resulting in donor/donor, donor/acceptor and
acceptor/acceptor pairing at the protein. Advanced single-molecule
excitation schemes like ALEX (alternating laser excitation) [44,45] or
PIE (pulsed interleaved excitation) [46] allow the selection and sub-
sequent analysis of the donor/acceptor population only. If there are no
position-dependent eﬀects on the dye, the distance between donor and
acceptor is not changed if the coupling site of donor and acceptor is
reversed. In our hands, stochastic labelling of the protein results in
homogeneous FRET eﬃciency distributions as recently shown for
Rpb4/7, a heterodimeric subcomplex of RNA polymerase, and human
Argonaute 2 [26].
4. Conclusions
Recent developments in the ﬁeld of genetic code expansion and
bioorthogonal chemistries open up the possibility to engineer a non-
canonical amino acid carrying a unique reactive side chain into a
human protein of interest and to couple a wide variety of probes to this
site including ﬂuorescent dyes, biotins, lipids, sugars, EPR labels,
crosslinkers via bioorthogonal chemistries [1,2]. This methodological
development opens up new analytical opportunities and is of special
importance for biochemical and biophysical studies including single-
molecule FRET measurements. We recently introduced the SLAM (site-
speciﬁc labelling of endogenous mammalian proteins for smFRET
measurements)-FRET workﬂow that overcomes many problems en-
countered so far when attempting to perform single-molecule FRET
measurements with human proteins [26] (e.g. not all human proteins
can be produced in insect cells that allow incorporation of unnatural
amino acids; lack of human posttranslational modiﬁcations when pro-
ducing the protein recombinantly in E. coli or insect cells; need for ar-
tiﬁcial crosslinking to stabilise a protein complex). The possibility to
perform smFRET measurements with fully native human proteins or
protein complexes with site-speciﬁcally engineered ﬂuorophores allows
integrated structure-function-dynamics investigations of human pro-
teins and protein complexes [47,48]. This approach can also provide
the opportunity to screen small molecule libraries for compounds that
prevent protein interactions for a given target in a high throughput
format as a readout for the multimerisation status is now easily
available even with minute amounts of protein (the readout would be
either simple co-localisation of the donor and acceptor ﬂuorophore or
FRET). Due to minimal sample requirements smFRET measurements
with labelled human proteins could be well adapted to 24-well or 96-
well formats allowing high throughput screening and even automatized
handling and preparation of samples.
Moreover, the possibility to introduce any desired modiﬁcation in a
site-speciﬁc manner paves the way for new mechanistic studies. For
example, proteins can be site-speciﬁcally linked to lipids, the small
protein SUMO (small ubiquitin-like modiﬁed), ubiquitin, sugars or
biotins. These modiﬁcations inﬂuence the activity, conformation and
cellular status of human proteins. This complexity of the eukaryotic
proteomic space becomes accessible and can be studied in detail with
site-speciﬁcally modiﬁed proteins. Also, spin labels for EPR measure-
ments [49] or (photoactive) crosslinkers could be site-speciﬁcally in-
troduced; proteins could be covalently linked for cryo-EM analysis or
attached to surfaces or linkers for single-molecule force measurements
via a biotin-streptavidin linkage for subsequent customised assays and
as part of advanced nanostructures.
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